The Board Meeting scheduled to be held today i.e. 30th May 2025 is adjourned for considering the Audited Financials for the Quarter and Year ended March 2025 due to unexpected health issue ....
Awaiting price reaction for this filing.
Ajel Limited has adjourned its Board Meeting originally scheduled for 30th May 2025, which was set to consider and approve the Audited Standalone and Consolidated Financial Results for Q4 and FY ended 31st March 2025. The meeting commenced at 4:00 P.M. and was adjourned at 8:45 P.M. due to the Managing Director experiencing unexpected health issues. The Board has decided to reconvene the meeting after a week's time at the same hour. The trading window for dealing in the company's shares remains closed until 48 hours after the declaration of results.
No direct financial impact on shareholders as this is a procedural postponement. Investors may see a brief delay in the announcement of FY25 audited results, but the reason cited (health issue) is non-financial and unlikely to affect the stock price materially.